N TSITIZIN HOSILALARINING ANTIDOT XUSUSIYATLARI

Authors

  • Latipova Shaxlo Bekdurdiyevna Urganch Davlat tibbiyet instituti Author

Keywords:

Tsitizin, N-tsitizin hosilalari, antidot, nikotinik retseptorlar, zaharlanish, organofosfatlar, farmakologiya, nikotin antagonizmi.

Abstract

Ushbu ilmiy tezisda o‘simlik alkaloidi bo‘lgan N-tsitizin (cytisine) va uning hosilalarining antidot xususiyatlari zamonaviy ilmiy manbalar asosida tahlil qilinadi. Tsitizin — bu nikotinik atsetilxolin retseptorlarining qisman agonisti bo‘lib, asosan tamaki qaramligini davolashda qo‘llanadi. So‘nggi yillarda uning farmakologik profili, toksik moddalarga qarshi himoya potensiali, xususan nikotin zaharlanishi, organofosfat birikmalar ta’siri va markaziy nerv tizimi toksikliklarida qo‘llash imkoniyatlari o‘rganilmoqda. Maqolada tsitizin hosilalarining molekulyar mexanizmlari, farmakodinamikasi va eksperimental natijalari umumlashtiriladi.

References

Tutka P., et al. Cytisine for the treatment of nicotine addiction. Pharmacological Reports, 2005, pp. 777–798.

Coe J.W., et al. Varenicline: an α4β2 nicotinic receptor partial agonist. Journal of Medicinal Chemistry, 2005, pp. 3474–3477.

Eddleston M., et al. Management of acute organophosphorus pesticide poisoning. Lancet, 2008, pp. 597–607.

Papke R.L., et al. The pharmacological properties of cytisine. Molecular Pharmacology, 1994, pp. 142–149.

Rollema H., et al. Pharmacological profile of cytisine. Neuropharmacology, 2010, pp. 220–229.

Stolerman I.P., Jarvis M.J. The scientific case that nicotine is addictive. Psychopharmacology, 1995, pp. 2–10.

Albuquerque E.X., et al. Nicotinic receptor mechanisms in organophosphate toxicity. Toxicology Letters, 2009, pp. 97–104.

West R., et al. Cytisine versus nicotine replacement for smoking cessation. New England Journal of Medicine, 2011, pp. 1193–1200.

Benowitz N.L. Nicotine toxicity and safety. Annual Review of Pharmacology and Toxicology, 1996, pp. 597–613.

Rollema H., et al. Preclinical pharmacology of varenicline. Biochemical Pharmacology, 2007, pp. 835–842.

Jeong S.H., et al. Pharmacokinetics of cytisine in humans. European Journal of Drug Metabolism and Pharmacokinetics, 2014, pp. 57–63.

Tutka P., Zatonski W. Cytisine in the treatment of nicotine dependence. Drugs, 2006, pp. 775–785.

Downloads

Published

2026-02-21

Issue

Section

Articles

How to Cite

Latipova , S. (2026). N TSITIZIN HOSILALARINING ANTIDOT XUSUSIYATLARI. Young Scientists, 4(13), 52-56. https://www.in-academy.uz/index.php/YO/article/view/53823
Innovative Academy RSC
Article metrics Views and PDF downloads
1 Views
0 Downloads